Global Neurological Disease Model Chip Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market size is projected to grow from US$ 53.6 million in 2024 to US$ 86.8 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Neurological Disease Model Chip Industry Forecast” looks at past sales and reviews total world Neurological Disease Model Chip sales in 2023, providing a comprehensive analysis by region and market sector of projected Neurological Disease Model Chip sales for 2024 through 2030. With Neurological Disease Model Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disease Model Chip industry.
This Insight Report provides a comprehensive analysis of the global Neurological Disease Model Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disease Model Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disease Model Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disease Model Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disease Model Chip.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disease Model Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Neurological Disease Model Chip market?
What factors are driving Neurological Disease Model Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurological Disease Model Chip market opportunities vary by end market size?
How does Neurological Disease Model Chip break out by Type, by Application?
The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
The global Neurological Disease Model Chip market size is projected to grow from US$ 53.6 million in 2024 to US$ 86.8 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Neurological Disease Model Chip Industry Forecast” looks at past sales and reviews total world Neurological Disease Model Chip sales in 2023, providing a comprehensive analysis by region and market sector of projected Neurological Disease Model Chip sales for 2024 through 2030. With Neurological Disease Model Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disease Model Chip industry.
This Insight Report provides a comprehensive analysis of the global Neurological Disease Model Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disease Model Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disease Model Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disease Model Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disease Model Chip.
The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disease Model Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Neuron Chip
- Brain Chip
- Brain Organ Chip
- Pharmaceutical R&D
- Neuroscience Research
- Clinical Diagnosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emulate
- CN Bio
- TissUse
- AxoSim Technologies
- Nortis
- Mimetas
- SynVivo
- Axion Biosystems
- Tara Biosystems
- InSphero
- Hesperos
- Kugelmeiers
- Ascendance Biotechnology
- BioIVT
- BGI Genomics
What is the 10-year outlook for the global Neurological Disease Model Chip market?
What factors are driving Neurological Disease Model Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurological Disease Model Chip market opportunities vary by end market size?
How does Neurological Disease Model Chip break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Disease Model Chip Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neurological Disease Model Chip by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neurological Disease Model Chip by Country/Region, 2019, 2023 & 2030
2.2 Neurological Disease Model Chip Segment by Type
2.2.1 Neuron Chip
2.2.2 Brain Chip
2.2.3 Brain Organ Chip
2.3 Neurological Disease Model Chip Sales by Type
2.3.1 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
2.3.2 Global Neurological Disease Model Chip Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neurological Disease Model Chip Sale Price by Type (2019-2024)
2.4 Neurological Disease Model Chip Segment by Application
2.4.1 Pharmaceutical R&D
2.4.2 Neuroscience Research
2.4.3 Clinical Diagnosis
2.5 Neurological Disease Model Chip Sales by Application
2.5.1 Global Neurological Disease Model Chip Sale Market Share by Application (2019-2024)
2.5.2 Global Neurological Disease Model Chip Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neurological Disease Model Chip Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Neurological Disease Model Chip Breakdown Data by Company
3.1.1 Global Neurological Disease Model Chip Annual Sales by Company (2019-2024)
3.1.2 Global Neurological Disease Model Chip Sales Market Share by Company (2019-2024)
3.2 Global Neurological Disease Model Chip Annual Revenue by Company (2019-2024)
3.2.1 Global Neurological Disease Model Chip Revenue by Company (2019-2024)
3.2.2 Global Neurological Disease Model Chip Revenue Market Share by Company (2019-2024)
3.3 Global Neurological Disease Model Chip Sale Price by Company
3.4 Key Manufacturers Neurological Disease Model Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurological Disease Model Chip Product Location Distribution
3.4.2 Players Neurological Disease Model Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROLOGICAL DISEASE MODEL CHIP BY GEOGRAPHIC REGION
4.1 World Historic Neurological Disease Model Chip Market Size by Geographic Region (2019-2024)
4.1.1 Global Neurological Disease Model Chip Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neurological Disease Model Chip Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neurological Disease Model Chip Market Size by Country/Region (2019-2024)
4.2.1 Global Neurological Disease Model Chip Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neurological Disease Model Chip Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neurological Disease Model Chip Sales Growth
4.4 APAC Neurological Disease Model Chip Sales Growth
4.5 Europe Neurological Disease Model Chip Sales Growth
4.6 Middle East & Africa Neurological Disease Model Chip Sales Growth
5 AMERICAS
5.1 Americas Neurological Disease Model Chip Sales by Country
5.1.1 Americas Neurological Disease Model Chip Sales by Country (2019-2024)
5.1.2 Americas Neurological Disease Model Chip Revenue by Country (2019-2024)
5.2 Americas Neurological Disease Model Chip Sales by Type (2019-2024)
5.3 Americas Neurological Disease Model Chip Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disease Model Chip Sales by Region
6.1.1 APAC Neurological Disease Model Chip Sales by Region (2019-2024)
6.1.2 APAC Neurological Disease Model Chip Revenue by Region (2019-2024)
6.2 APAC Neurological Disease Model Chip Sales by Type (2019-2024)
6.3 APAC Neurological Disease Model Chip Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurological Disease Model Chip by Country
7.1.1 Europe Neurological Disease Model Chip Sales by Country (2019-2024)
7.1.2 Europe Neurological Disease Model Chip Revenue by Country (2019-2024)
7.2 Europe Neurological Disease Model Chip Sales by Type (2019-2024)
7.3 Europe Neurological Disease Model Chip Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Disease Model Chip by Country
8.1.1 Middle East & Africa Neurological Disease Model Chip Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neurological Disease Model Chip Revenue by Country (2019-2024)
8.2 Middle East & Africa Neurological Disease Model Chip Sales by Type (2019-2024)
8.3 Middle East & Africa Neurological Disease Model Chip Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurological Disease Model Chip
10.3 Manufacturing Process Analysis of Neurological Disease Model Chip
10.4 Industry Chain Structure of Neurological Disease Model Chip
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurological Disease Model Chip Distributors
11.3 Neurological Disease Model Chip Customer
12 WORLD FORECAST REVIEW FOR NEUROLOGICAL DISEASE MODEL CHIP BY GEOGRAPHIC REGION
12.1 Global Neurological Disease Model Chip Market Size Forecast by Region
12.1.1 Global Neurological Disease Model Chip Forecast by Region (2025-2030)
12.1.2 Global Neurological Disease Model Chip Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Neurological Disease Model Chip Forecast by Type (2025-2030)
12.7 Global Neurological Disease Model Chip Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Emulate
13.1.1 Emulate Company Information
13.1.2 Emulate Neurological Disease Model Chip Product Portfolios and Specifications
13.1.3 Emulate Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Emulate Main Business Overview
13.1.5 Emulate Latest Developments
13.2 CN Bio
13.2.1 CN Bio Company Information
13.2.2 CN Bio Neurological Disease Model Chip Product Portfolios and Specifications
13.2.3 CN Bio Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CN Bio Main Business Overview
13.2.5 CN Bio Latest Developments
13.3 TissUse
13.3.1 TissUse Company Information
13.3.2 TissUse Neurological Disease Model Chip Product Portfolios and Specifications
13.3.3 TissUse Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 TissUse Main Business Overview
13.3.5 TissUse Latest Developments
13.4 AxoSim Technologies
13.4.1 AxoSim Technologies Company Information
13.4.2 AxoSim Technologies Neurological Disease Model Chip Product Portfolios and Specifications
13.4.3 AxoSim Technologies Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AxoSim Technologies Main Business Overview
13.4.5 AxoSim Technologies Latest Developments
13.5 Nortis
13.5.1 Nortis Company Information
13.5.2 Nortis Neurological Disease Model Chip Product Portfolios and Specifications
13.5.3 Nortis Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nortis Main Business Overview
13.5.5 Nortis Latest Developments
13.6 Mimetas
13.6.1 Mimetas Company Information
13.6.2 Mimetas Neurological Disease Model Chip Product Portfolios and Specifications
13.6.3 Mimetas Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mimetas Main Business Overview
13.6.5 Mimetas Latest Developments
13.7 SynVivo
13.7.1 SynVivo Company Information
13.7.2 SynVivo Neurological Disease Model Chip Product Portfolios and Specifications
13.7.3 SynVivo Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 SynVivo Main Business Overview
13.7.5 SynVivo Latest Developments
13.8 Axion Biosystems
13.8.1 Axion Biosystems Company Information
13.8.2 Axion Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
13.8.3 Axion Biosystems Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Axion Biosystems Main Business Overview
13.8.5 Axion Biosystems Latest Developments
13.9 Tara Biosystems
13.9.1 Tara Biosystems Company Information
13.9.2 Tara Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
13.9.3 Tara Biosystems Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Tara Biosystems Main Business Overview
13.9.5 Tara Biosystems Latest Developments
13.10 InSphero
13.10.1 InSphero Company Information
13.10.2 InSphero Neurological Disease Model Chip Product Portfolios and Specifications
13.10.3 InSphero Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 InSphero Main Business Overview
13.10.5 InSphero Latest Developments
13.11 Hesperos
13.11.1 Hesperos Company Information
13.11.2 Hesperos Neurological Disease Model Chip Product Portfolios and Specifications
13.11.3 Hesperos Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hesperos Main Business Overview
13.11.5 Hesperos Latest Developments
13.12 Kugelmeiers
13.12.1 Kugelmeiers Company Information
13.12.2 Kugelmeiers Neurological Disease Model Chip Product Portfolios and Specifications
13.12.3 Kugelmeiers Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kugelmeiers Main Business Overview
13.12.5 Kugelmeiers Latest Developments
13.13 Ascendance Biotechnology
13.13.1 Ascendance Biotechnology Company Information
13.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Portfolios and Specifications
13.13.3 Ascendance Biotechnology Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Ascendance Biotechnology Main Business Overview
13.13.5 Ascendance Biotechnology Latest Developments
13.14 BioIVT
13.14.1 BioIVT Company Information
13.14.2 BioIVT Neurological Disease Model Chip Product Portfolios and Specifications
13.14.3 BioIVT Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioIVT Main Business Overview
13.14.5 BioIVT Latest Developments
13.15 BGI Genomics
13.15.1 BGI Genomics Company Information
13.15.2 BGI Genomics Neurological Disease Model Chip Product Portfolios and Specifications
13.15.3 BGI Genomics Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 BGI Genomics Main Business Overview
13.15.5 BGI Genomics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Disease Model Chip Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neurological Disease Model Chip by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neurological Disease Model Chip by Country/Region, 2019, 2023 & 2030
2.2 Neurological Disease Model Chip Segment by Type
2.2.1 Neuron Chip
2.2.2 Brain Chip
2.2.3 Brain Organ Chip
2.3 Neurological Disease Model Chip Sales by Type
2.3.1 Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
2.3.2 Global Neurological Disease Model Chip Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neurological Disease Model Chip Sale Price by Type (2019-2024)
2.4 Neurological Disease Model Chip Segment by Application
2.4.1 Pharmaceutical R&D
2.4.2 Neuroscience Research
2.4.3 Clinical Diagnosis
2.5 Neurological Disease Model Chip Sales by Application
2.5.1 Global Neurological Disease Model Chip Sale Market Share by Application (2019-2024)
2.5.2 Global Neurological Disease Model Chip Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neurological Disease Model Chip Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Neurological Disease Model Chip Breakdown Data by Company
3.1.1 Global Neurological Disease Model Chip Annual Sales by Company (2019-2024)
3.1.2 Global Neurological Disease Model Chip Sales Market Share by Company (2019-2024)
3.2 Global Neurological Disease Model Chip Annual Revenue by Company (2019-2024)
3.2.1 Global Neurological Disease Model Chip Revenue by Company (2019-2024)
3.2.2 Global Neurological Disease Model Chip Revenue Market Share by Company (2019-2024)
3.3 Global Neurological Disease Model Chip Sale Price by Company
3.4 Key Manufacturers Neurological Disease Model Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurological Disease Model Chip Product Location Distribution
3.4.2 Players Neurological Disease Model Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROLOGICAL DISEASE MODEL CHIP BY GEOGRAPHIC REGION
4.1 World Historic Neurological Disease Model Chip Market Size by Geographic Region (2019-2024)
4.1.1 Global Neurological Disease Model Chip Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neurological Disease Model Chip Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neurological Disease Model Chip Market Size by Country/Region (2019-2024)
4.2.1 Global Neurological Disease Model Chip Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neurological Disease Model Chip Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neurological Disease Model Chip Sales Growth
4.4 APAC Neurological Disease Model Chip Sales Growth
4.5 Europe Neurological Disease Model Chip Sales Growth
4.6 Middle East & Africa Neurological Disease Model Chip Sales Growth
5 AMERICAS
5.1 Americas Neurological Disease Model Chip Sales by Country
5.1.1 Americas Neurological Disease Model Chip Sales by Country (2019-2024)
5.1.2 Americas Neurological Disease Model Chip Revenue by Country (2019-2024)
5.2 Americas Neurological Disease Model Chip Sales by Type (2019-2024)
5.3 Americas Neurological Disease Model Chip Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disease Model Chip Sales by Region
6.1.1 APAC Neurological Disease Model Chip Sales by Region (2019-2024)
6.1.2 APAC Neurological Disease Model Chip Revenue by Region (2019-2024)
6.2 APAC Neurological Disease Model Chip Sales by Type (2019-2024)
6.3 APAC Neurological Disease Model Chip Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurological Disease Model Chip by Country
7.1.1 Europe Neurological Disease Model Chip Sales by Country (2019-2024)
7.1.2 Europe Neurological Disease Model Chip Revenue by Country (2019-2024)
7.2 Europe Neurological Disease Model Chip Sales by Type (2019-2024)
7.3 Europe Neurological Disease Model Chip Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Disease Model Chip by Country
8.1.1 Middle East & Africa Neurological Disease Model Chip Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neurological Disease Model Chip Revenue by Country (2019-2024)
8.2 Middle East & Africa Neurological Disease Model Chip Sales by Type (2019-2024)
8.3 Middle East & Africa Neurological Disease Model Chip Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurological Disease Model Chip
10.3 Manufacturing Process Analysis of Neurological Disease Model Chip
10.4 Industry Chain Structure of Neurological Disease Model Chip
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurological Disease Model Chip Distributors
11.3 Neurological Disease Model Chip Customer
12 WORLD FORECAST REVIEW FOR NEUROLOGICAL DISEASE MODEL CHIP BY GEOGRAPHIC REGION
12.1 Global Neurological Disease Model Chip Market Size Forecast by Region
12.1.1 Global Neurological Disease Model Chip Forecast by Region (2025-2030)
12.1.2 Global Neurological Disease Model Chip Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Neurological Disease Model Chip Forecast by Type (2025-2030)
12.7 Global Neurological Disease Model Chip Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Emulate
13.1.1 Emulate Company Information
13.1.2 Emulate Neurological Disease Model Chip Product Portfolios and Specifications
13.1.3 Emulate Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Emulate Main Business Overview
13.1.5 Emulate Latest Developments
13.2 CN Bio
13.2.1 CN Bio Company Information
13.2.2 CN Bio Neurological Disease Model Chip Product Portfolios and Specifications
13.2.3 CN Bio Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CN Bio Main Business Overview
13.2.5 CN Bio Latest Developments
13.3 TissUse
13.3.1 TissUse Company Information
13.3.2 TissUse Neurological Disease Model Chip Product Portfolios and Specifications
13.3.3 TissUse Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 TissUse Main Business Overview
13.3.5 TissUse Latest Developments
13.4 AxoSim Technologies
13.4.1 AxoSim Technologies Company Information
13.4.2 AxoSim Technologies Neurological Disease Model Chip Product Portfolios and Specifications
13.4.3 AxoSim Technologies Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AxoSim Technologies Main Business Overview
13.4.5 AxoSim Technologies Latest Developments
13.5 Nortis
13.5.1 Nortis Company Information
13.5.2 Nortis Neurological Disease Model Chip Product Portfolios and Specifications
13.5.3 Nortis Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nortis Main Business Overview
13.5.5 Nortis Latest Developments
13.6 Mimetas
13.6.1 Mimetas Company Information
13.6.2 Mimetas Neurological Disease Model Chip Product Portfolios and Specifications
13.6.3 Mimetas Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mimetas Main Business Overview
13.6.5 Mimetas Latest Developments
13.7 SynVivo
13.7.1 SynVivo Company Information
13.7.2 SynVivo Neurological Disease Model Chip Product Portfolios and Specifications
13.7.3 SynVivo Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 SynVivo Main Business Overview
13.7.5 SynVivo Latest Developments
13.8 Axion Biosystems
13.8.1 Axion Biosystems Company Information
13.8.2 Axion Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
13.8.3 Axion Biosystems Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Axion Biosystems Main Business Overview
13.8.5 Axion Biosystems Latest Developments
13.9 Tara Biosystems
13.9.1 Tara Biosystems Company Information
13.9.2 Tara Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
13.9.3 Tara Biosystems Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Tara Biosystems Main Business Overview
13.9.5 Tara Biosystems Latest Developments
13.10 InSphero
13.10.1 InSphero Company Information
13.10.2 InSphero Neurological Disease Model Chip Product Portfolios and Specifications
13.10.3 InSphero Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 InSphero Main Business Overview
13.10.5 InSphero Latest Developments
13.11 Hesperos
13.11.1 Hesperos Company Information
13.11.2 Hesperos Neurological Disease Model Chip Product Portfolios and Specifications
13.11.3 Hesperos Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hesperos Main Business Overview
13.11.5 Hesperos Latest Developments
13.12 Kugelmeiers
13.12.1 Kugelmeiers Company Information
13.12.2 Kugelmeiers Neurological Disease Model Chip Product Portfolios and Specifications
13.12.3 Kugelmeiers Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kugelmeiers Main Business Overview
13.12.5 Kugelmeiers Latest Developments
13.13 Ascendance Biotechnology
13.13.1 Ascendance Biotechnology Company Information
13.13.2 Ascendance Biotechnology Neurological Disease Model Chip Product Portfolios and Specifications
13.13.3 Ascendance Biotechnology Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Ascendance Biotechnology Main Business Overview
13.13.5 Ascendance Biotechnology Latest Developments
13.14 BioIVT
13.14.1 BioIVT Company Information
13.14.2 BioIVT Neurological Disease Model Chip Product Portfolios and Specifications
13.14.3 BioIVT Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioIVT Main Business Overview
13.14.5 BioIVT Latest Developments
13.15 BGI Genomics
13.15.1 BGI Genomics Company Information
13.15.2 BGI Genomics Neurological Disease Model Chip Product Portfolios and Specifications
13.15.3 BGI Genomics Neurological Disease Model Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 BGI Genomics Main Business Overview
13.15.5 BGI Genomics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurological Disease Model Chip Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neurological Disease Model Chip Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Neuron Chip
Table 4. Major Players of Brain Chip
Table 5. Major Players of Brain Organ Chip
Table 6. Global Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 7. Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Table 8. Global Neurological Disease Model Chip Revenue by Type (2019-2024) & ($ million)
Table 9. Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2024)
Table 10. Global Neurological Disease Model Chip Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Neurological Disease Model Chip Sale by Application (2019-2024) & (K Units)
Table 12. Global Neurological Disease Model Chip Sale Market Share by Application (2019-2024)
Table 13. Global Neurological Disease Model Chip Revenue by Application (2019-2024) & ($ million)
Table 14. Global Neurological Disease Model Chip Revenue Market Share by Application (2019-2024)
Table 15. Global Neurological Disease Model Chip Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Neurological Disease Model Chip Sales by Company (2019-2024) & (K Units)
Table 17. Global Neurological Disease Model Chip Sales Market Share by Company (2019-2024)
Table 18. Global Neurological Disease Model Chip Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Neurological Disease Model Chip Revenue Market Share by Company (2019-2024)
Table 20. Global Neurological Disease Model Chip Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Neurological Disease Model Chip Producing Area Distribution and Sales Area
Table 22. Players Neurological Disease Model Chip Products Offered
Table 23. Neurological Disease Model Chip Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Neurological Disease Model Chip Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Neurological Disease Model Chip Sales Market Share Geographic Region (2019-2024)
Table 28. Global Neurological Disease Model Chip Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Neurological Disease Model Chip Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Neurological Disease Model Chip Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Neurological Disease Model Chip Sales Market Share by Country/Region (2019-2024)
Table 32. Global Neurological Disease Model Chip Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Neurological Disease Model Chip Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 35. Americas Neurological Disease Model Chip Sales Market Share by Country (2019-2024)
Table 36. Americas Neurological Disease Model Chip Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 38. Americas Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 39. APAC Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 40. APAC Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Table 41. APAC Neurological Disease Model Chip Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 43. APAC Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 44. Europe Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 45. Europe Neurological Disease Model Chip Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 47. Europe Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Neurological Disease Model Chip
Table 53. Key Market Challenges & Risks of Neurological Disease Model Chip
Table 54. Key Industry Trends of Neurological Disease Model Chip
Table 55. Neurological Disease Model Chip Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Neurological Disease Model Chip Distributors List
Table 58. Neurological Disease Model Chip Customer List
Table 59. Global Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Neurological Disease Model Chip Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Neurological Disease Model Chip Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Neurological Disease Model Chip Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Neurological Disease Model Chip Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Neurological Disease Model Chip Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Neurological Disease Model Chip Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Neurological Disease Model Chip Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Neurological Disease Model Chip Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Neurological Disease Model Chip Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Emulate Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 74. Emulate Neurological Disease Model Chip Product Portfolios and Specifications
Table 75. Emulate Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Emulate Main Business
Table 77. Emulate Latest Developments
Table 78. CN Bio Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 79. CN Bio Neurological Disease Model Chip Product Portfolios and Specifications
Table 80. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. CN Bio Main Business
Table 82. CN Bio Latest Developments
Table 83. TissUse Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 84. TissUse Neurological Disease Model Chip Product Portfolios and Specifications
Table 85. TissUse Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. TissUse Main Business
Table 87. TissUse Latest Developments
Table 88. AxoSim Technologies Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 89. AxoSim Technologies Neurological Disease Model Chip Product Portfolios and Specifications
Table 90. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AxoSim Technologies Main Business
Table 92. AxoSim Technologies Latest Developments
Table 93. Nortis Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 94. Nortis Neurological Disease Model Chip Product Portfolios and Specifications
Table 95. Nortis Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Nortis Main Business
Table 97. Nortis Latest Developments
Table 98. Mimetas Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 99. Mimetas Neurological Disease Model Chip Product Portfolios and Specifications
Table 100. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Mimetas Main Business
Table 102. Mimetas Latest Developments
Table 103. SynVivo Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 104. SynVivo Neurological Disease Model Chip Product Portfolios and Specifications
Table 105. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. SynVivo Main Business
Table 107. SynVivo Latest Developments
Table 108. Axion Biosystems Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 109. Axion Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
Table 110. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Axion Biosystems Main Business
Table 112. Axion Biosystems Latest Developments
Table 113. Tara Biosystems Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 114. Tara Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
Table 115. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Tara Biosystems Main Business
Table 117. Tara Biosystems Latest Developments
Table 118. InSphero Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 119. InSphero Neurological Disease Model Chip Product Portfolios and Specifications
Table 120. InSphero Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. InSphero Main Business
Table 122. InSphero Latest Developments
Table 123. Hesperos Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 124. Hesperos Neurological Disease Model Chip Product Portfolios and Specifications
Table 125. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Hesperos Main Business
Table 127. Hesperos Latest Developments
Table 128. Kugelmeiers Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 129. Kugelmeiers Neurological Disease Model Chip Product Portfolios and Specifications
Table 130. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Kugelmeiers Main Business
Table 132. Kugelmeiers Latest Developments
Table 133. Ascendance Biotechnology Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 134. Ascendance Biotechnology Neurological Disease Model Chip Product Portfolios and Specifications
Table 135. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Ascendance Biotechnology Main Business
Table 137. Ascendance Biotechnology Latest Developments
Table 138. BioIVT Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 139. BioIVT Neurological Disease Model Chip Product Portfolios and Specifications
Table 140. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. BioIVT Main Business
Table 142. BioIVT Latest Developments
Table 143. BGI Genomics Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 144. BGI Genomics Neurological Disease Model Chip Product Portfolios and Specifications
Table 145. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. BGI Genomics Main Business
Table 147. BGI Genomics Latest Developments
Table 1. Neurological Disease Model Chip Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Neurological Disease Model Chip Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Neuron Chip
Table 4. Major Players of Brain Chip
Table 5. Major Players of Brain Organ Chip
Table 6. Global Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 7. Global Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Table 8. Global Neurological Disease Model Chip Revenue by Type (2019-2024) & ($ million)
Table 9. Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2024)
Table 10. Global Neurological Disease Model Chip Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Neurological Disease Model Chip Sale by Application (2019-2024) & (K Units)
Table 12. Global Neurological Disease Model Chip Sale Market Share by Application (2019-2024)
Table 13. Global Neurological Disease Model Chip Revenue by Application (2019-2024) & ($ million)
Table 14. Global Neurological Disease Model Chip Revenue Market Share by Application (2019-2024)
Table 15. Global Neurological Disease Model Chip Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Neurological Disease Model Chip Sales by Company (2019-2024) & (K Units)
Table 17. Global Neurological Disease Model Chip Sales Market Share by Company (2019-2024)
Table 18. Global Neurological Disease Model Chip Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Neurological Disease Model Chip Revenue Market Share by Company (2019-2024)
Table 20. Global Neurological Disease Model Chip Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Neurological Disease Model Chip Producing Area Distribution and Sales Area
Table 22. Players Neurological Disease Model Chip Products Offered
Table 23. Neurological Disease Model Chip Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Neurological Disease Model Chip Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Neurological Disease Model Chip Sales Market Share Geographic Region (2019-2024)
Table 28. Global Neurological Disease Model Chip Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Neurological Disease Model Chip Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Neurological Disease Model Chip Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Neurological Disease Model Chip Sales Market Share by Country/Region (2019-2024)
Table 32. Global Neurological Disease Model Chip Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Neurological Disease Model Chip Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 35. Americas Neurological Disease Model Chip Sales Market Share by Country (2019-2024)
Table 36. Americas Neurological Disease Model Chip Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 38. Americas Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 39. APAC Neurological Disease Model Chip Sales by Region (2019-2024) & (K Units)
Table 40. APAC Neurological Disease Model Chip Sales Market Share by Region (2019-2024)
Table 41. APAC Neurological Disease Model Chip Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 43. APAC Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 44. Europe Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 45. Europe Neurological Disease Model Chip Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 47. Europe Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Neurological Disease Model Chip Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Neurological Disease Model Chip Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Neurological Disease Model Chip Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Neurological Disease Model Chip
Table 53. Key Market Challenges & Risks of Neurological Disease Model Chip
Table 54. Key Industry Trends of Neurological Disease Model Chip
Table 55. Neurological Disease Model Chip Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Neurological Disease Model Chip Distributors List
Table 58. Neurological Disease Model Chip Customer List
Table 59. Global Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Neurological Disease Model Chip Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Neurological Disease Model Chip Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Neurological Disease Model Chip Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Neurological Disease Model Chip Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Neurological Disease Model Chip Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Neurological Disease Model Chip Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Neurological Disease Model Chip Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Neurological Disease Model Chip Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Neurological Disease Model Chip Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Neurological Disease Model Chip Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Neurological Disease Model Chip Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Emulate Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 74. Emulate Neurological Disease Model Chip Product Portfolios and Specifications
Table 75. Emulate Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Emulate Main Business
Table 77. Emulate Latest Developments
Table 78. CN Bio Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 79. CN Bio Neurological Disease Model Chip Product Portfolios and Specifications
Table 80. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. CN Bio Main Business
Table 82. CN Bio Latest Developments
Table 83. TissUse Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 84. TissUse Neurological Disease Model Chip Product Portfolios and Specifications
Table 85. TissUse Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. TissUse Main Business
Table 87. TissUse Latest Developments
Table 88. AxoSim Technologies Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 89. AxoSim Technologies Neurological Disease Model Chip Product Portfolios and Specifications
Table 90. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AxoSim Technologies Main Business
Table 92. AxoSim Technologies Latest Developments
Table 93. Nortis Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 94. Nortis Neurological Disease Model Chip Product Portfolios and Specifications
Table 95. Nortis Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Nortis Main Business
Table 97. Nortis Latest Developments
Table 98. Mimetas Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 99. Mimetas Neurological Disease Model Chip Product Portfolios and Specifications
Table 100. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Mimetas Main Business
Table 102. Mimetas Latest Developments
Table 103. SynVivo Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 104. SynVivo Neurological Disease Model Chip Product Portfolios and Specifications
Table 105. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. SynVivo Main Business
Table 107. SynVivo Latest Developments
Table 108. Axion Biosystems Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 109. Axion Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
Table 110. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Axion Biosystems Main Business
Table 112. Axion Biosystems Latest Developments
Table 113. Tara Biosystems Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 114. Tara Biosystems Neurological Disease Model Chip Product Portfolios and Specifications
Table 115. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Tara Biosystems Main Business
Table 117. Tara Biosystems Latest Developments
Table 118. InSphero Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 119. InSphero Neurological Disease Model Chip Product Portfolios and Specifications
Table 120. InSphero Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. InSphero Main Business
Table 122. InSphero Latest Developments
Table 123. Hesperos Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 124. Hesperos Neurological Disease Model Chip Product Portfolios and Specifications
Table 125. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Hesperos Main Business
Table 127. Hesperos Latest Developments
Table 128. Kugelmeiers Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 129. Kugelmeiers Neurological Disease Model Chip Product Portfolios and Specifications
Table 130. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Kugelmeiers Main Business
Table 132. Kugelmeiers Latest Developments
Table 133. Ascendance Biotechnology Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 134. Ascendance Biotechnology Neurological Disease Model Chip Product Portfolios and Specifications
Table 135. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Ascendance Biotechnology Main Business
Table 137. Ascendance Biotechnology Latest Developments
Table 138. BioIVT Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 139. BioIVT Neurological Disease Model Chip Product Portfolios and Specifications
Table 140. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. BioIVT Main Business
Table 142. BioIVT Latest Developments
Table 143. BGI Genomics Basic Information, Neurological Disease Model Chip Manufacturing Base, Sales Area and Its Competitors
Table 144. BGI Genomics Neurological Disease Model Chip Product Portfolios and Specifications
Table 145. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. BGI Genomics Main Business
Table 147. BGI Genomics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurological Disease Model Chip
Figure 2. Neurological Disease Model Chip Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurological Disease Model Chip Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Neurological Disease Model Chip Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Neurological Disease Model Chip Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Neurological Disease Model Chip Sales Market Share by Country/Region (2023)
Figure 10. Neurological Disease Model Chip Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Neuron Chip
Figure 12. Product Picture of Brain Chip
Figure 13. Product Picture of Brain Organ Chip
Figure 14. Global Neurological Disease Model Chip Sales Market Share by Type in 2023
Figure 15. Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2024)
Figure 16. Neurological Disease Model Chip Consumed in Pharmaceutical R&D
Figure 17. Global Neurological Disease Model Chip Market: Pharmaceutical R&D (2019-2024) & (K Units)
Figure 18. Neurological Disease Model Chip Consumed in Neuroscience Research
Figure 19. Global Neurological Disease Model Chip Market: Neuroscience Research (2019-2024) & (K Units)
Figure 20. Neurological Disease Model Chip Consumed in Clinical Diagnosis
Figure 21. Global Neurological Disease Model Chip Market: Clinical Diagnosis (2019-2024) & (K Units)
Figure 22. Global Neurological Disease Model Chip Sale Market Share by Application (2023)
Figure 23. Global Neurological Disease Model Chip Revenue Market Share by Application in 2023
Figure 24. Neurological Disease Model Chip Sales by Company in 2023 (K Units)
Figure 25. Global Neurological Disease Model Chip Sales Market Share by Company in 2023
Figure 26. Neurological Disease Model Chip Revenue by Company in 2023 ($ millions)
Figure 27. Global Neurological Disease Model Chip Revenue Market Share by Company in 2023
Figure 28. Global Neurological Disease Model Chip Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Neurological Disease Model Chip Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 31. Americas Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 32. APAC Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 33. APAC Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 34. Europe Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 35. Europe Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 38. Americas Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 39. Americas Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Figure 40. Americas Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 41. Americas Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 42. United States Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 47. APAC Neurological Disease Model Chip Revenue Market Share by Region (2019-2024)
Figure 48. APAC Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 49. APAC Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 50. China Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 54. India Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 58. Europe Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Figure 59. Europe Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 60. Europe Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 61. Germany Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 62. France Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 69. Egypt Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurological Disease Model Chip in 2023
Figure 75. Manufacturing Process Analysis of Neurological Disease Model Chip
Figure 76. Industry Chain Structure of Neurological Disease Model Chip
Figure 77. Channels of Distribution
Figure 78. Global Neurological Disease Model Chip Sales Market Forecast by Region (2025-2030)
Figure 79. Global Neurological Disease Model Chip Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurological Disease Model Chip Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Neurological Disease Model Chip Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Neurological Disease Model Chip Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Neurological Disease Model Chip
Figure 2. Neurological Disease Model Chip Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurological Disease Model Chip Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Neurological Disease Model Chip Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Neurological Disease Model Chip Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Neurological Disease Model Chip Sales Market Share by Country/Region (2023)
Figure 10. Neurological Disease Model Chip Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Neuron Chip
Figure 12. Product Picture of Brain Chip
Figure 13. Product Picture of Brain Organ Chip
Figure 14. Global Neurological Disease Model Chip Sales Market Share by Type in 2023
Figure 15. Global Neurological Disease Model Chip Revenue Market Share by Type (2019-2024)
Figure 16. Neurological Disease Model Chip Consumed in Pharmaceutical R&D
Figure 17. Global Neurological Disease Model Chip Market: Pharmaceutical R&D (2019-2024) & (K Units)
Figure 18. Neurological Disease Model Chip Consumed in Neuroscience Research
Figure 19. Global Neurological Disease Model Chip Market: Neuroscience Research (2019-2024) & (K Units)
Figure 20. Neurological Disease Model Chip Consumed in Clinical Diagnosis
Figure 21. Global Neurological Disease Model Chip Market: Clinical Diagnosis (2019-2024) & (K Units)
Figure 22. Global Neurological Disease Model Chip Sale Market Share by Application (2023)
Figure 23. Global Neurological Disease Model Chip Revenue Market Share by Application in 2023
Figure 24. Neurological Disease Model Chip Sales by Company in 2023 (K Units)
Figure 25. Global Neurological Disease Model Chip Sales Market Share by Company in 2023
Figure 26. Neurological Disease Model Chip Revenue by Company in 2023 ($ millions)
Figure 27. Global Neurological Disease Model Chip Revenue Market Share by Company in 2023
Figure 28. Global Neurological Disease Model Chip Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Neurological Disease Model Chip Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 31. Americas Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 32. APAC Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 33. APAC Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 34. Europe Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 35. Europe Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Neurological Disease Model Chip Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Neurological Disease Model Chip Revenue 2019-2024 ($ millions)
Figure 38. Americas Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 39. Americas Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Figure 40. Americas Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 41. Americas Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 42. United States Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Neurological Disease Model Chip Sales Market Share by Region in 2023
Figure 47. APAC Neurological Disease Model Chip Revenue Market Share by Region (2019-2024)
Figure 48. APAC Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 49. APAC Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 50. China Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 54. India Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Neurological Disease Model Chip Sales Market Share by Country in 2023
Figure 58. Europe Neurological Disease Model Chip Revenue Market Share by Country (2019-2024)
Figure 59. Europe Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 60. Europe Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 61. Germany Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 62. France Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Neurological Disease Model Chip Sales Market Share by Application (2019-2024)
Figure 69. Egypt Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Neurological Disease Model Chip Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Neurological Disease Model Chip in 2023
Figure 75. Manufacturing Process Analysis of Neurological Disease Model Chip
Figure 76. Industry Chain Structure of Neurological Disease Model Chip
Figure 77. Channels of Distribution
Figure 78. Global Neurological Disease Model Chip Sales Market Forecast by Region (2025-2030)
Figure 79. Global Neurological Disease Model Chip Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Neurological Disease Model Chip Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurological Disease Model Chip Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Neurological Disease Model Chip Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Neurological Disease Model Chip Revenue Market Share Forecast by Application (2025-2030)
